DOT NRCME Medical Examiner Certification Training Program

This activity is intended for MD’s, DO’s PA’s, NP’s, and Chiropractors engaged in the DOT/ FMCSA medical examination and certification/ qualification of commercial motor vehicle drivers.

After completing this activity, the participant should be better able to:

At the conclusion of this activity, the participant should be able to:

• Discuss how the U.S. Department of Transportation (DOT) driver fitness requirements affect the physical examination and subsequent driver certification status.
• Perform a more thorough and accurate examination in compliance with federal D.O.T. regulations, therefore lowering the potential for serious accident or injury resulting from a driver who was not medically qualified to drive.

• Apply knowledge of FMCSA’s driver physical qualifications standards and advisory criteria to findings gathered during the driver’s medical examination; and
• Identify the driver’s medical and physical qualifications for safely operating a commercial motor vehicle (CMV) in interstate commerce.
• Discuss the history of FMCSA and its position within the Department of Transportation including its establishment by the Motor Carrier Safety Improvement Act of 1999 and emphasize FMCSA’s Mission to reduce crashes, injuries and fatalities involving large trucks and buses.
• Describe the responsibilities, work schedules, physical and emotional demands and lifestyle among CMV drivers and how these vary by the type of driving.
• Discuss factors and job tasks that may be involved in a driver’s performance, such as:
  • Loading and unloading trailers;
  • Inspecting the operating condition of the CM; and
  • Schedules
  • Irregular work, rest, and eating patterns/ dietary choices.
  • Identification of the driver and obtaining, reviewing, and documenting driver medical history, including prescription and over-the-counter medications

• Explain the FMCSA physical examination requirements and advisory criteria in relationship to conducting the driver’s physical examination of all body systems.
• Describe the FMCSA diagnostic testing requirements and the medical examiner’s ability to request further testing and evaluation by a specialist.
• Inform and educate drivers about medications and non-disqualifying medical conditions that require remedial care

• Discuss the medical examiner’s obligation to consider potential risk to public safety and the driver’s medical and physical qualifications to drive safely when issuing a Medical Examiner’s Certificate, when to qualify/disqualify the driver and how to determine the expiration date of the certificate
• Demonstrate the required FMCSA medical examination report forms, appropriate methods for recording the medical examination findings and the rationale for certification decisions

Dr. Lawrence Earl, MD
Medical Director
National Academy DOT Medical Examiners

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The National Academy of DOT Medical Examiners (NADME).  Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The Postgraduate Institute for Medicine designates this enduring material for a maximum of 18 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The maximum number of hours awarded for this Continuing Nursing Education activity is 18 contact hours.

Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty report the following:

Dr. Lawrence Earl, MD has nothing to disclose.

The PIM planners and managers have nothing to disclose. The NADME planners have nothing to disclose.

During the period January 1, 2017 through to April 1, 2021, participants must read the learning objectives and faculty disclosures and successfully complete the online course and pass the final examination. In order to obtain your CME/CE certificate, participants must read the learning objectives and faculty disclosures and successfully complete the online course and pass the final examination. To obtain a CME/CE certificate additional instructions are provided at the conclusion of activity.

After successfully completing the course you will be provided a link to CME University to complete an activity evaluation.

Upon registering and completing the activity evaluation, your certificate will be made available immediately.

Internet

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.